[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.

Details

Serval ID
serval:BIB_56C05C3716CD
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.
Journal
Circulation. Cardiovascular imaging
Author(s)
Liebich A., Bundschuh R.A., Pfob C.H., Kircher M., Wienand G., Raake P., Nekolla S.G., Schottelius M., Higuchi T., Rieger M., Lapa C.
ISSN
1942-0080 (Electronic)
ISSN-L
1941-9651
Publication state
Published
Issued date
11/2024
Peer-reviewed
Oui
Volume
17
Number
11
Pages
e016992
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Accumulation of CXCR4 (C-X-C motif chemokine receptor 4)-positive immune cells after acute myocardial infarction (AMI) can be visualized by positron emission tomography. For a broader clinical application, there is a need for CXCR4-directed radiotracers labeled with isotopes that can be used with single-photon emission computed tomography (SPECT). We report on the detection of CXCR4 expression after AMI in humans using the novel tracer [ <sup>99m</sup> Tc]-PentixaTec.
In this retrospective analysis, 9 patients with AMI after mechanical revascularization underwent myocardial inflammation imaging with [ <sup>99m</sup> Tc]-PentixaTec SPECT/computed tomography and rest perfusion SPECT imaging. Tracer uptake in the infarcted area, spleen, bone marrow, and blood pool were used for semiquantitative analysis and calculation of signal-to-background ratios. The extent and intensity of SPECT-derived inflammatory changes were compared with serological markers and perfusion defects.
CXCR4-directed SPECT was positive in all patients. Increased CXCR4 expression was only detected in areas with diminished perfusion corresponding to the affected vessel in coronary angiography, with a signal-to-background ratio (infarcted area-to-blood pool) of 2.36±0.74. Uptake in bone marrow and spleen showed a significant correlation with CXCR4 expression in the infarcted areas (r=0.73 and P=0.03 for spleen and r=0.81 and P=0.008 for bone marrow, respectively). The extent and intensity of SPECT-derived inflammatory changes showed no significant association with serum troponin, CK (creatine kinase), leukocyte, or CRP (C-reactive protein) levels.
This is the first report of in vivo CXCR4 imaging after AMI using a <sup>99m</sup> Tc-labeled tracer. Increased CXCR4 expression was observed locally in the infarcted region and was related to a systemic inflammatory response in the reticuloendothelial system. This proof-of-concept investigation demonstrates the general feasibility of evaluating the inflammation-related CXCR4 expression in the myocardium after AMI using conventional scintigraphy or SPECT and might, thus, broaden its worldwide application in clinical practice.
Keywords
Humans, Myocardial Infarction/metabolism, Myocardial Infarction/diagnostic imaging, Retrospective Studies, Receptors, CXCR4/metabolism, Male, Radiopharmaceuticals, Female, Single Photon Emission Computed Tomography Computed Tomography/methods, Middle Aged, Aged, Myocardium/metabolism, Myocardium/pathology, Organotechnetium Compounds, Myocardial Perfusion Imaging/methods, Predictive Value of Tests, Coronary Angiography/methods, Up-Regulation, diagnostic imaging, myocardial infarction, myocytes, cardiac, stroke volume, ventricular function, left
Pubmed
Create date
15/11/2024 16:38
Last modification date
22/11/2024 17:55
Usage data